Lisa M. Shewchuk - Concepedia

Author

Lisa M. Shewchuk

Also Known As

L M Shewchuk, L. M. SHEWCHUK, L. Shewchuk, L.M. Shewchuk, Lisa M Shewchuk, Lisa M. Shewchuk, Lisa Shewchuk, M. Muelbaier

121

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)Research Triangle Park Foundation South College Harvard University GlaxoSmithKline (Germany)

About

Lisa M. Shewchuk is an author at GlaxoSmithKline (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	41	4.4K
2	Biochemistry	26	33	2.6K
3	Natural Sciences	25	31	2.6K
4	Engineering	1	1	29
5	Public Health	1	1	14

Lisa M. Shewchuk

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib) Edgar R. Wood, Anne T. Truesdale, Octerloney B. McDonald, Cancer Research Crystal StructureMolecular BiologyCell GrowthTumor BiologyDrug Effect	2004	1.1K
Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1<i>H</i>-indol-5-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) Jeffrey M. Axten, Jesús R. Medina, Yanhong Feng, Journal of Medicinal Chemistry Chemoprevention StrategyChemical BiologyPharmaceutical ChemistryTumor BiologyMolecular Pharmacology	2012	601
Escherichia coli biotin holoenzyme synthetase/bio repressor crystal structure delineates the biotin- and DNA-binding domains. Keith P. Wilson, Lisa M. Shewchuk, Richard G. Brennan, Proceedings of the National Academy of Sciences BiosynthesisBiochemistryProtein AssemblyProtein FoldingNatural Sciences	1992	294
Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis H. Neal Bramson, J. Corona, Stephen T. Davis, Journal of Medicinal Chemistry Oxindole-based InhibitorsOxindole-based CompoundsLigand DockingCell CycleHeterocycle Chemistry	2001	267
The Drosophila Orphan Nuclear Receptor DHR38 Mediates an Atypical Ecdysteroid Signaling Pathway K.D. Baker, Lisa M. Shewchuk, Tatiana Kozlova, Cell Developmental BiologyDevelopmental GeneticsGeneticsHormonal ReceptorMolecular Genetics	2003	236
Binding Mode of the 4-Anilinoquinazoline Class of Protein Kinase Inhibitor: X-ray Crystallographic Studies of 4-Anilinoquinazolines Bound to Cyclin-Dependent Kinase 2 and p38 Kinase Lisa M. Shewchuk, Anne M. Hassell, Bruce Wisely, Journal of Medicinal Chemistry Medicinal ChemistryDrug TargetBiochemistry4-Anilinoquinazolines RepresentNatural Sciences	1999	231
Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors Stephen T. Davis, Bill Benson, H. Neal Bramson, Science Cdk InhibitorsChemoprevention StrategyHair LossMedicinePharmacology	2001	167
Structure of the Tie2 RTK Domain Lisa M. Shewchuk, Anne M. Hassell, Byron Ellis, Structure Computational TopologyTie2 Rtk Domain	2000	145
X-ray Crystal Structure of the Novel Enhanced-Affinity Glucocorticoid Agonist Fluticasone Furoate in the Glucocorticoid Receptor−Ligand Binding Domain Keith Biggadike, Randy K. Bledsoe, Anne M. Hassell, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryBiochemistryG Protein-coupled ReceptorMedicine	2008	112
6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases Edgar R. Wood, Lisa M. Shewchuk, Byron Ellis, Proceedings of the National Academy of Sciences Combinatorial ChemistryMedicinal ChemistryBiochemistryCovalent BondMedicine	2008	110

Page 1